Protective effects of Bisoprolol against anthracycline-induced cardiomyopathy in breast cancer patient
Phase 3
Recruiting
- Conditions
- chemotherapy induced cardiomyopathy in breast cancer patients.
- Registration Number
- IRCT20130701013828N8
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 90
Inclusion Criteria
Patients with breast cancer
Patients with indication for AC (doxorubicin hydrochloride (Adriamycin) and cyclophosphamide) regimen for chemotherapy
Patients agreement
Exclusion Criteria
Patients non compliance
Patients who have cardiovascular problems
Have previously undergone chest radiotherapy
Patients who have allergy to Bisoprolol
Patients currently taking beta-blockers
Patients who have contraindicated for use beta blockers.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method